139 related articles for article (PubMed ID: 6757638)
1. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
2. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
[No Abstract] [Full Text] [Related]
4. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
Bagatin J; Rumboldt Z; Jurisić M; Vujić D
Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
[No Abstract] [Full Text] [Related]
5. Deapril-ST for senile dementia.
Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
[No Abstract] [Full Text] [Related]
6. [Co-dergocrinmesylate in elderly hypertensive patients].
Bock KD; Welzel D; Dennler HJ
MMW Munch Med Wochenschr; 1982 Dec; 124(48):1095-8. PubMed ID: 6817133
[No Abstract] [Full Text] [Related]
7. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
8. Hydergine for schizophrenia.
Cohen MR; Pary R; Burns R
J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
[No Abstract] [Full Text] [Related]
9. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
10. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
11. Event related evoked potentials in dementia.
Breeze RW
Br J Clin Pract Suppl; 1985 Jun; 39():43-4. PubMed ID: 3929815
[No Abstract] [Full Text] [Related]
12. [Evaluation of the effectiveness and tolerance of dihydroergotoxine and alpha methyldopa in the therapy of arterial hypertension in the elderly with senile cerebral insufficiency].
Bergamasco B; Scarzella L; Turri D
Recenti Prog Med; 1987 Apr; 78(4):166-70. PubMed ID: 3628936
[No Abstract] [Full Text] [Related]
13. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
14. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
Hughes JR; Williams JG; Currier RD
J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
[TBL] [Abstract][Full Text] [Related]
15. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
[No Abstract] [Full Text] [Related]
16. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
17. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
Yesavage JA; Hollister LE; Burian E
J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
[TBL] [Abstract][Full Text] [Related]
18. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Yesavage JA; Adey M
Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
[No Abstract] [Full Text] [Related]
19. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
20. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
[Next] [New Search]